[{"address1": "105 Bradford Road", "address2": "Suite 420", "city": "Wexford", "state": "PA", "zip": "15090", "country": "United States", "phone": "724 934 6467", "website": "https://coeptistx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. David  Mehalick", "age": 54, "title": "Co-Founder, Chairman of the Board, CEO & President", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 361615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Christine Elise Sheehy", "age": 56, "title": "Co-Founder and VP of Compliance & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 225999, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel Alexander Yerace", "age": 40, "title": "Co-Founder, VP of Operations & Director", "yearBorn": 1983, "fiscalYear": 2022, "totalPay": 360346, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Cogley M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Colleen  Delaney M.D., M.Sc.", "age": 56, "title": "CSO & Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4992, "open": 0.4842, "dayLow": 0.47, "dayHigh": 0.4988, "regularMarketPreviousClose": 0.4992, "regularMarketOpen": 0.4842, "regularMarketDayLow": 0.47, "regularMarketDayHigh": 0.4988, "beta": -0.789, "forwardPE": -0.6233766, "volume": 101599, "regularMarketVolume": 101599, "averageVolume": 213339, "averageVolume10days": 473150, "averageDailyVolume10Day": 473150, "bid": 0.4701, "ask": 0.49, "bidSize": 1000, "askSize": 800, "marketCap": 16371840, "fiftyTwoWeekLow": 0.325, "fiftyTwoWeekHigh": 2.19, "fiftyDayAverage": 0.5671, "twoHundredDayAverage": 1.07002, "currency": "USD", "enterpriseValue": 15960827, "floatShares": 17996082, "sharesOutstanding": 34108000, "sharesShort": 65451, "sharesShortPriorMonth": 23751, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0019, "heldPercentInsiders": 0.34441003, "heldPercentInstitutions": 0.13876, "shortRatio": 0.47, "shortPercentOfFloat": 0.0023, "bookValue": 0.152, "priceToBook": 3.1578948, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -20185160, "trailingEps": -0.61, "forwardEps": -0.77, "enterpriseToEbitda": -0.795, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "COEP", "underlyingSymbol": "COEP", "shortName": "Coeptis Therapeutics Holdings, ", "longName": "Coeptis Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1608215400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "820436ab-e838-3404-bbe6-691814b0374c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.48, "targetHighPrice": 4.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.5, "targetMedianPrice": 3.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 1411510, "totalCashPerShare": 0.041, "ebitda": -20074450, "totalDebt": 1000480, "quickRatio": 2.421, "currentRatio": 2.55, "debtToEquity": 19.963, "returnOnAssets": -1.42903, "returnOnEquity": -3.43431, "freeCashflow": -6460007, "operatingCashflow": -6393080, "financialCurrency": "USD", "trailingPegRatio": null}]